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1. Introduction 
Experts from all continents  have called for  the emerging countries to start chronic kidney 
disease prevention and screening programs, develop end-stage renal disease registries and 
start or further strengthen transplantation programs through International as well as 
regional collaborations to acquire the information, technology, experience and skills 
necessary whilst acknowledging these goals are ambitious (Remuzzi, Perico, et al. 2010).  
Transplantation is the optimal renal replacement therapy for children with end-stage 
renal disease. Compared with dialysis, successful transplantation in children and 
adolescents not only ameliorates uremic symptoms but also allows for significant 
improvement of delayed growth, sexual maturation, and psychosocial functioning. The 
child with a well-functioning kidney can enjoy a quality of life that cannot be achieved by 
dialysis therapy (Uchida 2010). 
Although renal transplantation is an excellent option for the treatment of uremic children, it 
is more difficult compared to adults due to different etiologies often congenital, difficult 
surgical technique(van Heurn and deVries  2009), size match problems of the donor kidney 
and the post-operative hemodynamic effects due to poorly managed chronic renal failure 
and its effects upon growth and development. Most importantly, the lack of expertise, 
financial restraints and low-level national prioritization adds to the problem and prevents 
the establishment of fully-fledged pediatric renal transplant programs in developing 
countries (Bamgboye, 2009).  
However, despite the negativism (Muthusethupathi & Shivakumar 1993), many medical 
personnel in developing countries have attempted to bridge the gap (Usta et al. 2008), often 
successfully and have developed pediatric kidney transplant programs (Badmus et al. 2005) 
(Kandus et al 2009). Doctors embarking on such programs would inevitably feel the punch 
as healthcare in developing countries are less funded than developed nations (0.8 to 4% vs. 
10 to 15%, respectively), and must contend against approximately 1/3 of the population 
living below the poverty line ($1US/day), poor literacy (58% males/29% females), and less 
access to portable water and basic sanitation. Cultural and societal constraints combine with 
these economic obstacles. Donor shortage is a universal problem. Post-transplant infections 
are a major problem in developing countries, with 15% developing tuberculosis, 30% 
cytomegalovirus, and nearly 50% bacterial infections. The solutions may seem simplistic: 
alleviate poverty, educate the general population, and expand the transplant programs in 
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the public sector hospitals where commerce is less likely to play a major role. This is not 
forthcoming as in most developing countries it is not the governments’ priority. The SIUT 
model in Pakistan, funded by a community-government partnership is an exception to the 
rule and sustainable (Rizvi & Naqvi 1997). Over the last 15 years, it has operated by 
complete financial transparency, public audit and accountability. The scheme has proven 
effective and currently 110 transplants/year are performed, with free after care and 
immunosuppressive drugs. Confidence has been built in the community to attract strong 
donations of money, equipment and medicines (Rizvi et al. 2003). 
According to the databases maintained by North American Pediatric Renal Transplant Co-
operate Study (NAPRTCS) and the United States Renal Data System (USRDS) the 1, 2, and 5 
year survival rates for primary live donor kidney transplantation (LDKT) were 98%, 97%, 
95% respectively. The graft survival rate at 1 year and 7 years for primary LDKT were 92% 
and 74% respectively. According to the United Kingdom Transplant (UKT) report, the graft 
survival rate for all pediatric recipients during the 1 and 5 year were 79% and 68%, 
respectively. Developed centers attribute such excellent results to technical improvements in 
tissue typing and donor-recipient cross matching, modification of immune-suppression 
protocols and rigorous donor-recipient selection. (Porrett et al. 2009) 
Despite many limitations, Sri Lanka embarked upon a pediatric kidney transplant 
programme in July 2004 amidst various adversities to offer some hope to children dying of 
ESRF. Most were transplanted pre-emptively as there was no established dialysis 
programme for children in Sri Lanka. Renal transplantation is considered pre-emptive if it 
occurs before the initiation of dialysis and it is not considered detrimental for graft survival 
compared to dialyzed children (Jung et al. 2010). In the literature, pre-emptive 
transplantation has been shown not only to reduce the costs of renal replacement therapy 
but also to avoid the long-term adverse effect of dialysis (Haberal et al 2009)  and often 
involve a live donor that also appear to be slightly more advantageous compared to graft 
survival rates observed following deceased donor transplantation (Ng et al 2009). On the 
other hand pre-transplant dialysis modality, neither HD nor PD affects the outcome of renal 
transplantation (Caliskan et al. 2009). 
Initiating a pediatric program in a developing country is more difficult (Rizvi et al. 2001). 
We experienced at the inception, due to lack of chronic renal failure (CRF) or dialysis 
programme for children, most children presenting late and displaying complications of CRF 
such as severe anemia, hyper-dynamic circulation, cardiomegaly, metabolic bone disease, 
growth stunting and poor nutritional state. A plasma urea level of 40 – 50 mmol/ litre 
(normal range 2.7 – 7.0 mmol/l) preoperatively was not an uncommon finding. Since pre-
emptive transplantation was the only option, we noted at the initial stages of the programme 
that, most were not capable cardiovascularly to handle massive fluid and electrolyte shifts that 
occur during the immediate post transplant period. A polyuric-transplanted adult kidney 
would bring down the plasma urea to very low levels within 24-48 hours and this contributed 
to the onset of cerebral edema and convulsions. Inability to monitor plasma cyclosporin levels 
at short notice also contributed to the high incidence of seizures. Thus, elective mechanical 
ventilation postoperatively was useful until such time the postoperative polyuric phase was 
subsiding. Furthermore, the rapid onset pulmonary edema occurred 2-3 days after 
transplantation in a few cases. This was associated with a rapidly rising CVP, for example, 
from a stable 12cm of H2O to 25cm H2O despite accurate fluid balancing and appeared to be 
related to a rapid onset-myocardial weakness perhaps precipitated by precipitous electrolyte 
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losses (e.g. PO4 3- )(Sakhaee, 2010) other than what was replaced i.e. Na+ and K+. These 
patients needed dobutamine as an inotrope to improve cardiac output and resolve pulmonary 
edema in addition to 1-2 doses of frusemide. Low calcium and low magnesium levels that may 
ensue due to polyuria could be a contributory factor.  
Inadequate chronic renal failure (CRF) supportive care programme led to children 
presenting for transplantation have many co-morbid factors that made them vulnerable to 
higher peri-operative and anesthetic risks and difficulties in management. Limited 
laboratory, operating theatre and supplies of pharmaceutical agents, and the relatively 
inexperienced work force added to the shortcomings.  
Expert inputs from multi disciplinary teams including pediatric nephrologists, transplant 
surgeons, and pediatric intensivists are imperative to provide optimum care in the peri-
operative period for the transplant recipient. However, such expertise are hard to come by 
in the developing world and doctors involved in transplantation should be prepared to 
exceed their boundaries and provide the care necessary for these children irrespective of the 
time of the day.  
For better outcomes in renal transplantation, it is necessary to optimize medical conditions 
associated with long-term renal impairment prior to surgery. In the developed world, a 
kidney transplant centre for children would be supported by many specialists, namely, 
transplant surgeons, pediatric nephrologists, dieticians, clinical pharmacists, social workers, 
dialysis teams, home care teams etc to achieve the above set goals. However, this is not 
feasible for a transplant centre in a developing country. Often the only specialist available 
would be a general surgeon with transplantation skills, general pediatrician with 
nephrology interest, and trained nurses. There may not be a social worker, pharmacist, 
dietician to assist holistic clinical management of the patient. Despite all these drawbacks, 
the outcomes of kidney transplantation i.e. the graft and patient survival can be similar in 
developing countries in the short-term, even in children (Wisaanuyotin & Jiravuttipong  
2009)  to that of established centers in the developed world, but at what expense? This 
chapter looks at this issue. 
2. The pre-operative shortcomings 
The pre-operative status of children admitted for renal transplantation in the context of 
nutritional status, body weight, hemoglobin, and blood urea is far from ideal due to poor 
management of ESRD resulting from the lack of facilities and inadequacies in dialysis and 
non-availability of dedicated chronic renal failure management programs. In an ideal centre, 
they would have their recipients at near normal physical status through aggressive 
nutritional programs despite being on dialysis. 
In our centre, among 29 (20 male) children receiving kidney transplantation  aged median 10 
years (range 2-16),the mean (± SD) pre-transplant hemoglobin and blood urea were 9.36 ± 
2.46g/dl and 2l.97 ± 10.17 mmol/l respectively. Nearly a ⅔ (n=19) were on regular 
antihypertensive treatment. Of them, 1 patient (3.57%) had haemodialysis (HD), 7(25%) 
peritoneal dialysis (PD) and 3(10.71%) both prior to transplant. Seventeen (60.71%) were 
pre-emptive transplants. Preoperative blood transfusion to correct anemia was not 
attempted and it is also considered unimportant to improve outcomes (Aalten et al. 2009). 
The children in ESRF were cared for in the general pediatric ward, mostly assisted by 
parents or guardians. Supplementary funding came from external resources.  
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3. The operative difficulties 
In established centers, the operative difficulties in pediatric transplantation are mainly 
urological (e.g. VUR  12.4%, ureteral stricture 5%, anastomotic leak 2%, ureteral necrosis 1%, 
and incrustative pyelitis  0.5%) and vascular (arterial stricture  7.2%, arterial thrombosis 2%, 
venous thrombosis 1% ) (Irtan et al. 2010) . Donors aged less than six years were a risk factor 
of vascular complications leading to graft loss, whereas patients with PUV had more 
complications that are urological. Overall, patient and graft survival is 93.1% and 84% at 5-
years, respectively. Surgical complications remain a major cause of graft loss (12%) and 
morbidity in children's kidney transplantation (38.9%).  
Among the difficulties encountered during anesthesia, that also has an impact on 
postoperative care includes poor cardio-respiratory reserve due to cardiomegaly/myopathy 
(resulting from chronic anemia, uremia and hypertension) and pleural, pericardial effusions, 
anemia and liver dysfunction. Cardiac dysfunction and excessive bleeding were the 
commonest complications encountered under anesthesia during operation. It was not 
uncommon for some children with poor control of hypertension, cardiomyopathy with an 
EF of 35-40%, and body weight below 3rd centile to be operated. 
4. A unique set of postoperative problems 
In addition to providing good analgesia, the postoperative care of renal transplant recipients 
include establishment of hemodynamic stability, maintaining adequate perfusion of the 
newly transplanted kidney and prevention and treatment of complications resulting from 
fluid imbalance, electrolyte imbalance or myocardial weakness.  
The post operative complications encountered in a poorly nourished child with established 
complications of ESRD such as anemia, osteodystrophy, hypertension, cardiac failure were 
markedly different to what was described in most published work that involves well 
prepared, adequately dialyzed and well nourished children who seek kidney 
transplantation in the developed world.  
4.1 The poly-uric phase 
During the immediate post transplant period the urine output via the transplanted kidney 
can reach 1-2 liters / hour. Managing this phenomenon in a child of 10 kg where the total 
blood volume is only 700 ml can be a daunting task requiring fluid balancing and 
replacement every 15 minutes. Thus, one patient needs constant attention of several nurses 
to keep the fluid and electrolytes in balance. Provision of a work force to cater for this need 
is not an easy task in this part of the world. 
During the poly-uric phase, hypokalemia and hypophosphateamia (Sakhaee 2010) are 
common complications due to unrestrained loss of these electrolytes in urine. This can lead 
to severe myocardial weakness and arrhythmias. Appropriate cardiac support and 
anticipation of such problems are needed to be avoided to avert disaster.  The potassium 
loss in the diuretic phase can lead to severe hypokalemia, unless replacement fluids are 
replenished with at least 5 mmol/liter of KCl. 
4.2 Non functioning transplanted kidney 
The transplanted kidney may not function as a result of well-recognized causes such as, (a) 
acute rejection (b) acute vascular thromboses and (c) acute tubular necrosis. However, we 
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noted several extraneous factors contributing to a non functioning transplanted kidney. 
These include (a) high CVP (b) high intra abdominal pressure (c) obstructed or leaking 
ureter and (d) a relatively low systolic pressure that cannot provide adequate perfusion 
pressure for the transplanted kidney. It was also easy to overload these children, especially 
in whom the transplanted kidney did not work immediately postoperatively. Thus, careful 
restraint is also necessary in fluid management to avoid the need for urgent dialysis that is 
not promptly achievable in this part of the world. 
4.3 Heart failure and pulmonary edema 
This is usually seen 24-48 hours after transplantation during the latter part of the poly-uric 
phase. The onset of pulmonary oedema can be very rapid and florid (within a few minutes) 
and can occur even with meticulous fluid balancing. Thus, it is likely that an acquired 
myocardial weakness contributing to this complication, most probably due to electrolyte 
depletion especially phosphate. It should be noted that even in advanced centers, nearly 
1/3rd of post transplant deaths are attributed to cardio-vascular events (Koshy et al 2009). 
However, some other centers that record a low mortality rate following pediatric renal 
transplantation observe a majority of deaths due to malignancies and infections but have no 
impact of cardiovascular disease (Allain-Launay et al. 2009). On the other hand careful 
follow-up studies have revealed that repolarization abnormalities shown on an 
electrocardiogram of pre-RT patients improved significantly after RT (QTc dispersion 
50.8+/-37.3 to 37.4+/-11.9 msec, P=0.009) and left ventricular hypertrophy with increased 
LV mass index of pre-RT patients regressed remarkably after RT (LV mass index 120.9+/-
40.5 to 69.2+/-14.5 g/m2, P<0.001). Still  LV mass was significantly higher in RT patients 
than the controls (54.0+/-9.6 g/m2, P<0.001). Compared to the controls, the RT patients 
showed diastolic dysfunction (lower E/A ratio and higher isovolumic relaxation time) and 
lower myocardial performance (higher LV Tei index and weaker strain pattern)( Kim et al. 
2009). Other investigators too have observed persistent diastolic dysfunction following 
kidney transplantation in children (Ten Harkel et al . 2009). 
4.4 Convulsions 
Although this would be commonly alluded to drug toxicity (e.g. cyclosporine), in our set up, 
this could result from rapid loss of urea through the poly-uric transplanted kidney leading to a 
reverse osmosis and cerebral edema. Thus, the need for mechanical ventilation especially in 
children who had high blood urea levels pre-operatively (e.g. over 30 mmol/l) is justifiable. 
4.5 Bleeding diathesis 
This often results from preoperative liver dysfunction (due to chronic congestion) and anti-
platelet agents used for the prevention of acute vascular thrombosis. In chronically anemic 
patients, usually aspirin is avoided as the resulting bleed will not stop unless and until 
almost an exchange transfusion has occurred and the transfused platelets have taken effect. 
The need for leucocyte depleted blood to minimize the risk of sensitization, cryo precipitate 
and fresh frozen plasma in the management of this case scenario which is often an 
unbearable burden for our support services.  
4.6 Hyperglycemia 
Often a hyperglycemic state is noted, especially in children during the poly-uric phase. This 
is a direct result of the use of saline/dextrose solutions far exceeding the amounts the body 
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can handle metabolically during the given time. The hyperglycemia noted in this post 
operative phase is not usually associated with a metabolic derangement as seen in, for 
example, in diabetic keto acidosis and it is often impossible to normalize glucose levels 
through insulin therapy during the ongoing  replacement therapy with dextrose/saline. The 
use of, for example, 0.45% saline alone is also harmful due to its hypo tonicity. In our 
experience, this resultant hyperglycemia is relatively harmless and resolves spontaneously 
once the poly-uric phase is over. 
4.7 Drug monitoring 
It is not possible to monitor drug levels as much as one would like and more often than not 
an empirical dosage adjustment is carried out. 
4.8 Sepsis 
The mortality of pediatric renal transplant recipient is 4 to 4.5 % in the long term; and in 40-
45% this mortality, is caused by infection.   
4.9 Our experience 
From among the 29 children receiving kidney transplantation in our centre over the last 6 
years,, all children received a standard general anesthetic (Biriulina e al 2008), balanced 
using a low-flow inhalational isoflurane with non- invasive BP monitoring combined with 
internal jugular vein catheterization for CVP monitoring. The major component of infusion 
therapy was freshly frozen plasma and leukocyte depleted blood to correct anemia and 
operative blood loss.  
In our cohort, all were admitted to the ICU for postoperative mechanical ventilation 
following transplantation. The need to maintain adult blood pressures in children to drive 
the transplanted adult kidney with added problems of splinted diaphragm and a large 
proportion of the cardiac output diverting through the adult transplanted kidney imposed 
further difficulties for the already strained cardiovascular system in children. Thus, most 
children needed post operative intensive care necessitating inotropes and mechanical 
ventilation support.  In our cohort, the mean (±SD) duration of mechanical ventilation was 
4.59 ± 2.77 days while the mean (±SD) ICU stay was 6.44 ± 3.35 days. Post operative ICU 
complications occurred in 85.71%.    
Hypertension (53%), heart failure (32%) and convulsions (32%) were the commonest 
problems. Hyperglycemia (25%), bleeding diathesis (25%), temporary transplant kidney 
failure needing dialysis, acute exacerbation of asthma, low calcium, lung collapse, hypo-
natremia, paralytic ileus, and cyclosporine toxicity were among the other complications. No 
ICU deaths of post renal transplant patients were reported. 
We are only relieved that there were no patient or graft losses especially at this early phase 
of the program. This helped us build the much needed confidence of the public and that of 
colleagues. The experiences gained by the surgeon, nephrologists and anesthesiologist 
abroad in developed countries, contributed to this favorable outcome as they all functioned 
with a degree of anticipation for known complications and prevention. The nursing staff 
had no previous exposure but had learnt rapidly on the job using their intensive care skills 
to manage these cases. 
It was not possible to make any statistically significant causal inferences with the present 
study as it comprised of a small number of cases and had relatively short duration of follow 
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up. However, medical professionals develop the pattern of recognition necessary for 
infrequent clinical entities, through confrontation with real life demonstrations or lively 
papers best examples being case reports and case series. In this context, this paper would 
help those who are envisaging kidney transplant programmes in the developing world with 
limited resources.  
5. Limitations 
In a recent review, collating 16 reports of 300 pediatric transplants in the developing world 
found that recipients were older than 6 years and donors were living relatives in more than 
94% of the series. Cyclosporine, azathioprin and steroids were the mainstay of 
immunosuppression and in many centers, the high costs of drugs resulted in noncompliance 
and discontinuation of immunosuppression. Therefore, acute rejection rates were high, 
more than 40% in half of the series. One-year and 5-year survival rates for grafts were 89-
98% and 67-84% and for patients 88-98% and 65-90%, respectively. Major causes of graft loss 
were chronic rejection, acute rejection and infection and for the patients, it was infection. 
Growth analysis was not generally reported but when reported the deficit remains or gets 
worse. They concluded that high rejection and infection rates result in poor patient and graft 
survival (Rizvi et al  2009). 
With increased awareness, improved resources, and more health professionals trained in the 
field, it is likely that the renal transplantation would be routine in Sri Lanka as in many 
other countries. Although it offers survival advantage to these children, it is a complex 
procedure and is not without complications. The financial implications of costly regular 
medications these children need is an intolerable blow to the affected families and hence we 
are working towards meeting these costs via charity.  
Improving survival and quality of life for kidney transplant recipients in developing 
countries in the long-term is an awesome task. A recent review looking into factors affecting 
long-term outcome after renal transplantation in childhood, summarized in the table below 
would bring useful hints for the clinicians involved in caring for these children and adults in 
the developing world.  
6. Conclusion 
Kidney transplantation in the current context in a developing country may warrant a 
significant duration of postoperative ICU therapy in children. Since chronic dialysis also 
increases morbidity in these patients as it is associated with cardiovascular damage, 
impaired cognitive development and retardation of growth, pre-emptive kidney 
transplantation in children with ESRD, seems the treatment of choice in the developing 
world.  
Minimizing the risk of chronic allograft nephropathy is invariably a major task during 
follow up. Appropriate titration of the immunosuppressive agents of the high-risk patients 
(such as in those with higher serum creatinine level ) will be very important. Compliance 
can be improved by regular supervision and education of the patients and the parents and 
being empathetic towards their problems and needs, (especially those of the adolescent 
child) and also by minimizing the unnecessary hospital admissions and clinic visits, making 
the drug prescriptions as less complicated as possible and timely attending to the unwanted 
side effects of the drugs.  
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TRANSPLANT OUTCOME 
DETERMINANTS
WHAT IS ALREADY KNOWN 
Factors influencing outcome 
 
 Available resources affect patient selection, follow-
up and drug regimens 
 Community attitudes influence treatment of high-
risk patients such as neonates and children with 
handicaps 
 Some diagnoses are more common in particular 
ethnic backgrounds and patient and graft survival 
are affected by racial group  
 The outcome is generally superior for LD 
transplantation 
Patient survival 
 
 The mortality rate of children on the waiting list is 
55 per 1000 at risk 
 The overall mortality rate, with a relative risk of 
death after transplantation is 12.7-times higher 
than that of the age-related general population 
Overall patient survival  
 
 Between 70% and 100% at 5 years 
 Between 75% to 95% at 10 years 
 Between 83% to 94% at 15 years 
 Between 54% to 86% at 20 years 
 81%  at 25-years. 
Effect of recipient age  
 
 Mortality twice as high in those < 5 years of age 
than in those 6 to 10 years old 
 5-year survival rate of over 97% in under 6 year 
olds 
 91% 10-year survival rate in those weighing <15 kg 
at transplantation 
 87% 15-year survival rate in those <11 kg at 
transplantation  
Effect of donor type  
 
 Small benefit of LD on mortality at all ages up to 
5 years after transplantation 
 The survival rate for recipients of LDs,  96.1% 
5 years after transplantation  
 LD has a particular benefit for the very young 
child: 5-year patient survival rates for recipients 
less than 2 years old was 86% following LD and 
70% following DD 
Causes of death after 
transplantation  
 Cardiovascular disease (CVD) 30-36% 
 Infection 24–56%  
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  Malignancy 11-20% 
 Other important factors (a) non-concordance with 
medications, or treatment withdrawal  (b) obesity 
Comparison of mortality after 
transplantation with mortality 
on dialysis  
 
 lifespan of a child on dialysis is 40–60 years less, 
with a transplant, 20–25 years less, than that of age- 
and race-matched general populations 
 Eighty percent of patients on HD, 83% of those on 
PD and 93% of those with a transplant survive 
5 years 
 Mortality rates are seven-times higher in those 
who have been on dialysis for longer than they 
have had a transplant  
 Treatment with dialysis is associated with a risk 
more than four-times as high as for renal 
transplantation. 
 Most of the increased mortality in children on 
dialysis is due to CVD 
 Adolescents who had undergone pre-emptive 
transplantation have a better survival rate. 
Effect of race  
 
 Poorer outcomes for Afro-Americans than for the 
white population due to increased incidence of 
cardiovascular deaths by approximately 1.6 times.  
 Among black patients, cardiac deaths occurred in 
11% of transplant recipients and 34% of dialysis 
patients, and, among white patients, 9% and 25%, 
respectively 
Overall transplant survival  
 
 Current projected half-life 10 years.  
 Given a median age at transplantation of 13 years, 
50% of all current pediatric kidney recipients will 
need a second graft before the age of 25 years  
 Overall 5-year transplant survival varies between 
44% to 95%  
 at 5 years, 23%–95% at 10 years, 35% at 15 years [8] 
and 21–36% at 20 years. 
 Graft survival of repeat transplants are slightly 
lower than first grafts.  
 When DDs were used, graft survival rates at 1, 3 
and 5 years were 79%, 69%, and 62%, compared 
with 74%, 60%, and 47%, respectively, for the 
repeat transplants 
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TRANSPLANT OUTCOME 
DETERMINANTS
WHAT IS ALREADY KNOWN 
 For LDs, graft survival rates for 1,3 and 5 years 
were 91%, 83%, and 76% compared to 86%, 78%, 
and 72%, respectively, for repeat transplants. 
Effect of recipient age  
 
 Graft survival  at 1 year and 5 years 
 71% and 60% in those under the age of 2 years at 
transplantation,  
 83% and 64% in those aged 3 to 12 years 
 85% and 57% in those aged 13 to 21 years  
 In adolescents, as a group, have the worst graft 
survival rate of all ages 
Effect of donor age  
 
 Kidneys from deceased donors aged 11–17 years 
do best, with a 73% 5-year survival 
 Transplant survival of 55% after 5 years, for donors 
<6 years of age, and of 60% for donors over that 
age 
 5-year graft survival rate from donors <1 year of 
age 60%  and to 70% for donors aged 1 year to 
5 years 
Effect of donor type  
 
 Living related donation (LD) benefit outcome, graft 
survival 75% - 85% at 10 years, compared to 46% 
for DDs 
 LRD is of particular benefit to the recipient under 
2 years of age, 5-year graft survival 86%  compared 
to 38% following DD 
Effect of pre-emptive 
transplant  
 
 Transplant survival better in patients receiving a 
pre-emptive transplant compared with those 
undergoing PD and HD.  
 Graft loss resulting from vascular thrombosis is 
more common in children who undergo PD than in 
those who on HD  
 Graft survival between those not on dialysis and 
those on dialysis of 82% and 69%, respectively, at 
6 years 
 Waiting time on dialysis is an independent risk 
factor for failure of LRD transplants in adolescents 
Recurrent diseases  
 
 Diseases that recur after transplantation with a 
potential to affect outcome include FSGS, 
membranoproliferative glomerulonephritis 
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TRANSPLANT OUTCOME 
DETERMINANTS
WHAT IS ALREADY KNOWN 
(MPGN) and haemolytic uraemic syndrome (HUS) 
 Oxalate will continue to be deposited in the 
transplant if liver transplantation is not undertaken 
in patients with hyperoxaluria.  
 Nephrotic syndrome can recur in patients with 
congenital nephrotic syndrome, and anti-
glomerular basement membrane (anti-GBM) 
nephritis in patients with Alport’s syndrome, both 
due to the development of antibody to the 
‘missing’ protein.  
 FSGS recurs in approximately 30% of transplants 
Human leukocyte antigen 
matching  
 
 Donor-specific HLA mismatching is a risk for poor 
outcome 
 Worst outcome has been observed for two HLA-
DR mismatched grafts 
 000 and favourably matched kidneys (100, 010, 110 
HLA-A, -B, -DR mismatches) survived longest 
 Sensitised patients [panel reactive antibodies 
(PRA) > 40%]have a poorer outcome 
 Donor antigen-specific hyporeactivity correlates 
with better graft function 
Immunosuppression  
 
 The use of MMF in association with ciclosporin is 
associated with better outcome at 5 years than a 
similar regimen using AZA, transplant survival’s 
being 90.7% for MMF and 68.5% for AZA patients.  
 Cumulative rejection-free survival was also better 
in the MMF group, at 51.2% versus 37.0% in AZA 
patients.  
 Tacrolimus is significantly more effective than 
ciclosporin in both preventing acute rejection and 
maintaining graft function, with a 4-year 
transplant survival rate of 86% and 69%, 
respectively 
Concordance with therapeutic 
regimens  
 
 Non-concordance with therapeutic regimens 
affects all ages, but particularly adolescence.  
 Non-concordance is the main contributor for late 
graft loss, accounting for 71% of cases, and was a 
particular problem in Afro-American recipients 
Hypertension   Very common after transplantation, and its 
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TRANSPLANT OUTCOME 
DETERMINANTS
WHAT IS ALREADY KNOWN 
 incidence varies with time, ranging from 46%, 40%, 
and 66% of children at 1, 5, and 10 years, 
respectively. 
 Hypertension is a significant and independent 
predictor of poor long-term transplant function, 
regardless of the number of rejection episodes or 
transplant function at 1 year. 
Bladder dynamics  
 
 Transplantation into an abnormal urinary tract is 
associated with a high incidence of urological and 
infectious complications but no effect on patient 
survival or transplant outcome. 
 Careful surveillance of lower urinary tract function 
by urodynamic evaluation is essential before 
transplantation.  
 Reflux does not need to be corrected before 
transplantation, unless it is causing symptoms or 
infection .
Laparoscpic donor 
nephrectomy  
 
 Despite longer warm ischaemia and cold ischaemia 
times in LDs, graft outcome does not seem to be 
affected. 
Final height and incidence of 
obesity 
 
 Improvements in pre-transplantation management, 
particularly nutrition, have led to a better height 
attainment at transplantation 
 Decline in steroid dosing as immunosuppression 
has a positive benefit on growth. Patients who 
received recombinant human growth hormone 
(rHGH) suggest that final height is better than for 
those not receiving it. 
 Obesity, defined by a body mass index (BMI) >95th 
centile, is increasing in the transplant population 
(12.4% after 1995 and 8% before 1995) and seems to 
be more common in girls.
Psychosocial outcome 
 
 Psychosocial outcome seems to be better after 
transplantation than for patients on dialysis. 
 Employment: Several studies have revealed 
satisfactory employment levels., The range of 
occupations is broad, with a normal average 
working time each week. 
 Relationships: Successful relationships are reported 
50% married
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 Physical morbidity:  Co-morbidity was found in 
40% of all patients: motor, hearing, or visual 
disabilities were found in 19%. Bone disease, 
headaches, itching, and tremors were the most 
reported disabling problems. Other complications 
included osteoporosis in 53% of patients, avascular 
bone necrosis in 13%, post-transplantation diabetes 
mellitus in 10%, and hypertension in 60%.  
 Education:  Distribution of educational level was 
lower than national averages: 27.4% were at the 
lowest level versus 3% of the general population, 
41.4% were at the middle level, 31.2% had reached 
the baccalaureate level, and 11% had followed a 
university course.
Independence  
 
 46% lived in their parents’ home 
 54% lived independently 
Table 1. A summary of long-term outcome after renal transplantation in childhood (Rees 
2009). 
In spite of increase graft survival, mortality rates of renal transplant patients remain higher 
than the normal population. Cardio-vascular diseases, de-novo malignancy and infections 
are the commonest causes of death in the long run. Careful management of hypertension, 
left ventricular hypertrophy, dyslipidaemias and calcium and phosphate homeostasis, from 
the pre-transplant period, would help to reduce the cardio-vascular related deaths. 
Incidence of infections and malignancy can be reduced by the appropriate selection of the 
immune-suppressive drugs with timely tailoring off the dosages in patients, who are at 
lower risk for rejection.  
Another important challenge ahead is to optimize the care given to the patient with chronic 
kidney disease or CRF. One of the main obstacles that prevent this is the late presentation of 
these patients. Increased awareness of the health personnel and the general public regarding 
identification of the patients with renal problems and appropriate management of them will 
invariably reduce the incidence of ESRF, and better care provided to the CRF patients will 
delay the progression to end stage and will also reduce the pre-operative co-morbidities.  
In addition, the provision of regular medication, improving laboratory facilities, 
establishment of pediatric dialysis programmes and increasing the number of resource 
persons (pediatric transplant surgeons, pediatric nephrologists, pediatric anesthetists and 
trained paramedical personnel) are important goals to be achieved in the future, to assure 
successful ongoing transplant programs in the developing world. 
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